L3VLUP
ProSign in

PCRX in the 13F filings

Pacira Biosciences Inc · CUSIP 695127100

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Dec 2025
the date the book describes
Filed
19 Feb 2026
latest of these filings; the earliest 10 Feb 2026
Managers listing it
28
at least, of 95 tracked, among listed positions
Comparable managers
92
filed both Q3 2025 and Q4 2025; 4 listed it in both
Shares listed
8,680,914
combined, among listed positions
Reported value
$225m
combined, at the quarter end

Among the 92 comparable managers: 17 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +28,189.

Managers listing PCRX in Q4 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

28 of 28 holders

ActionFiling
D. E. Shaw & Co.2,039,927$53munder 0.1%Added+97,78417 Feb 2026 (the filing on sec.gov)
Renaissance Technologies LLC1,884,001$49m0.08%Trimmed-254,20012 Feb 2026 (the filing on sec.gov)
Balyasny Asset Management LLC945,979$24munder 0.1%Trimmed-939,09217 Feb 2026 (the filing on sec.gov)
Citadel Advisors LLC819,768$21munder 0.1%Added+748,59017 Feb 2026 (the filing on sec.gov)
Wellington Management Group LLP518,537$13munder 0.1%Trimmed-9,97817 Feb 2026 (the filing on sec.gov)
Two Sigma Investments LP451,852$12munder 0.1%Added+218,85817 Feb 2026 (the filing on sec.gov)
Jane Street Group LLC385,984$10.0munder 0.1%Added+239,31512 Feb 2026 (the filing on sec.gov)
Invesco Ltd244,679$6.3munder 0.1%Trimmed-272,74519 Feb 2026 (the filing on sec.gov)
Voloridge Investment Management LLC234,442$6.1munder 0.1%Trimmed-28,28117 Feb 2026 (the filing on sec.gov)
PDT Partners LLC169,565$4.4m0.28%Trimmed-4,20017 Feb 2026 (the filing on sec.gov)
AQR Capital Management LLC137,233$3.6munder 0.1%Trimmed-3,16817 Feb 2026 (the filing on sec.gov)
Millennium Management LLC122,606$3.2munder 0.1%Added+51,84817 Feb 2026 (the filing on sec.gov)
Two Sigma Advisers LP94,800$2.5munder 0.1%Added+30,10017 Feb 2026 (the filing on sec.gov)
Verition Fund Management LLC85,389$2.2munder 0.1%Newnew13 Feb 2026 (the filing on sec.gov)
Fidelity (FMR LLC)73,896$1.9munder 0.1%Trimmed-27,92817 Feb 2026 (the filing on sec.gov)
Quantbot Technologies LP67,242$1.7m0.06%Added+46,83410 Feb 2026 (the filing on sec.gov)
Squarepoint Ops LLC57,349$1.5munder 0.1%Added+4,99613 Feb 2026 (the filing on sec.gov)
Arrowstreet Capital LP53,198$1.4munder 0.1%Added+11,40513 Feb 2026 (the filing on sec.gov)
AllianceBernstein LP52,830$1.4munder 0.1%Trimmed-1417 Feb 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc51,982$1.3munder 0.1%Added+2,00117 Feb 2026 (the filing on sec.gov)
Caxton Associates LLP49,996$1.3munder 0.1%Added+4,51513 Feb 2026 (the filing on sec.gov)
Freestone Grove Partners LP36,832$953kunder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Susquehanna International Group LLP27,294$706kunder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Janus Henderson Group Ltd23,319$603kunder 0.1%Held017 Feb 2026 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC23,304$603kunder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Page 1 of 2

Largest increases and reductions, by shares

Q3 2025 to Q4 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (4)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
4 in Q3 2024 to 3 in Q2 2026
Drawing every quarter on file…

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

PCRX and LLY →PCRX and JNJ →PCRX and VRTX →Choose a stock to compare with PCRX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own PCRX, latest filings →Back to the 13F Explorer →